DPIIT recognised startup Government of India
Startup India
Reprosci Biosciences Private Limited - life sciences in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹17.24 Lakh
▲ 435% YoY
Net loss · FY 2023
₹60.72 Lakh
Net margin -352.2%
EBITDA · FY 2023
-₹53.97 Lakh
EBITDA margin -313.1%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹14.18 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Reprosci Biosciences Private Limited
Data last updated:
Reprosci Biosciences Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 29 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85100KA2021PTC154968. Its GSTIN is 29AALCR4755K1ZN (Karnataka).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹14.18 Lakh. It is led by directors including Sejal Ullas Shah and Ketul Pragneshkumar Patel.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Nasscom Coe – Iot Third Floor No 29/A(E) 27th Main 7th Cross Sector 1 Hsr Layout, Bangalore, Karnataka, India – 560102.
As per the financials filed for FY 2023, the company reported a revenue of ₹17.24 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹60.72 Lakh (net margin -352.2%) and EBITDA of -₹53.97 Lakh (EBITDA margin -313.1%).
The company is associated with 1 brand: Reprosci Biosciences. The company has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹4.58 Cr; the latest was in December 2022.
Reprosci Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0130710). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website reprosci.health.
Company details
CIN U85100KA2021PTC154968
Registration Number 154968
Incorporation Date 29 November 2021
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0130710
Recognitions & Rankings of Reprosci Biosciences
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-KR-03-0130710
Contact details
Reprosci Biosciences Private Limited's registered office is in Bangalore, Karnataka. Its website is reprosci.health. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNasscom Coe – Iot Third Floor No 29/A(E) 27th Main 7th Cross Sector 1 Hsr Layout, Bangalore, Karnataka, India – 560102
- IndustryLife Sciences, Biotechnology
To see the full contact details of Reprosci Biosciences Private Limited, buy the company report.
Comprehensive company report
Reprosci Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Reprosci Biosciences operates one associated brand: Reprosci Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Reprosci Biosciences is focused on reproductive health solutions. | reprosci.health |
Business activity
The main business activity of Reprosci Biosciences is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Reprosci Biosciences Private Limited, buy the company report.
Financials of Reprosci Biosciences Private Limited
FY 2023 filings availableReprosci Biosciences Private Limited reported revenue of ₹17.24 Lakh (up 435% YoY) for FY 2023.
Revenue · FY 2023
₹17.24 Lakh ▲ 435%
Net loss · FY 2023
₹60.72 Lakh margin -352.2%
EBITDA · FY 2023
-₹53.97 Lakh margin -313.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 435%
EBITDA CAGR growth
1 year
▼ 33%
Revenue rose 435% in the latest year. EBITDA fell 33% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹53.97 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹60.72 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -313.1% | |
| Net Profit Margin | -352.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Reprosci Biosciences Private Limited, buy the company report.
Board of directors of Reprosci Biosciences Private Limited
Reprosci Biosciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sejal Ullas Shah | Director | 29 Nov 2021 | 4 Years 10 Months | Current |
| Ketul Pragneshkumar Patel | Director | 02 Aug 2023 | 3 Years 2 Months | Current |
| Ravi Shankar Swamy Also directs: R & R Family Health Services LLP, Peopletech Healthcare LLP, Reviverays Healthcare Technologies Private Limited and 1 more | Director | 24 Dec 2021 | 4 Years 10 Months | Current |
| Mahendra Budharam Narwaria Also directs: Curovis Pharmacy LLP, Asian Bariatrics Private Limited, Asian Med Horizon Private Limited and 3 more | Director | 29 Nov 2021 | 4 Years 10 Months | Current |
Auditor
Reprosci Biosciences Private Limited is audited by SN MEHTA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SN MEHTA & ASSOCIATES | FY 2022 | 106306W |
Shareholding
The shareholding of Reprosci Biosciences Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Reprosci Biosciences Private Limited, buy the company report.
Deals & funding
Reprosci Biosciences Private Limited has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹4.58 Cr; the latest was in December 2022.
Total deals
4
Funding rounds
3
Secondary share transfer
1
Disclosed funding
₹4.58 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2022 | Funding round | ₹1.5 Cr | Investors: Ullas Shah Huf, 2 individuals |
| Mar 2022 | Funding round | ₹3 Cr | Investors: Ullas Shah Huf, 2 individuals |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Ullas Shah Huf, an individual Seller: 2 individuals |
| Mar 2022 | Funding round | ₹7.8 Lakh | Investors: Madhusudan Advisory Services Limited, 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Reprosci Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reprosci Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Reprosci Biosciences Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
Active EPFO establishments
1
GST
Reprosci Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AALCR4755K1ZN | Karnataka | Active | 22 Dec 2021 |
To see the full GST registrations and return filing status of Reprosci Biosciences Private Limited, buy the company report.
Recent activity
Reprosci Biosciences Private Limited has 5 board changes on record since 2021: 4 appointments and 1 cessation. The latest: Ketul Pragneshkumar Patel was appointed as Director on 02 Aug 2023.
AGM
Reprosci Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Appointed
Ketul Pragneshkumar Patel was appointed as Director.
Filing
Reprosci Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
Ceased
Ravi Shankar Swamy ceased to be Additional Director.
Appointed
Ravi Shankar Swamy was appointed as Director.
Appointed
Mahendra Budharam Narwaria was appointed as Director.
Appointed
Sejal Ullas Shah was appointed as Director.
Incorporation
29 Nov 2021
Reprosci Biosciences Private Limited was registered on 29 Nov 2021 with Roc Bangalore & aged 4 years 10 months as per MCA records.
Frequently asked questions
Reprosci Biosciences is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 29 November 2021 (5+ years old) and is registered under CIN U85100KA2021PTC154968.
Reprosci Biosciences has 4 current directors:
- Sejal Ullas Shah - Director
- Ketul Pragneshkumar Patel - Director
- Ravi Shankar Swamy - Director
- Mahendra Budharam Narwaria - Director
The latest financial statements of Reprosci Biosciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Reprosci Biosciences is 29AALCR4755K1ZN, registered in Karnataka.
The CIN (Corporate Identification Number) of Reprosci Biosciences is U85100KA2021PTC154968. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reprosci Biosciences was incorporated on 29 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Reprosci Biosciences has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹4.58 Cr; the latest was in December 2022.
Ketul Pragneshkumar Patel was appointed as Director on 02 Aug 2023. Ravi Shankar Swamy ceased to be Additional Director on 30 Sep 2022. Ravi Shankar Swamy was appointed as Director on 24 Dec 2021. Reprosci Biosciences has 5 board changes on record in total.
Yes, Reprosci Biosciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Reprosci Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0130710).